Adverse

Adverse Drug Reactions

Adverse drug reactions (ADRs) are harmful or unintended responses to medications that occur at normal therapeutic doses. They are a significant concern in clinical practice and can lead to morbidity, mortality, and increased healthcare costs. Understanding ADRs is crucial for healthcare professionals to ensure patient safety and effective pharmacotherapy.

Classification

ADRs can be classified into several types based on their characteristics:

Type A (Augmented)

Type A reactions are dose-dependent and predictable based on the pharmacological properties of the drug. They are the most common type of ADRs and include side effects such as hypoglycemia from insulin or bleeding from anticoagulants.

Type B (Bizarre)

Type B reactions are not dose-dependent and are unpredictable. They often involve immune-mediated responses, such as anaphylaxis from penicillin or Stevens-Johnson syndrome from certain anticonvulsants.

Type C (Chronic)

Type C reactions are associated with long-term drug therapy and include effects like osteoporosis from prolonged use of corticosteroids.

Type D (Delayed)

Type D reactions occur after some time has passed since drug exposure, such as carcinogenesis or teratogenesis.

Type E (End of use)

Type E reactions occur when a drug is withdrawn, leading to withdrawal symptoms, such as opioid withdrawal syndrome.

Type F (Failure)

Type F reactions are unexpected failures of therapy, such as antibiotic resistance.

Risk Factors

Several factors can increase the risk of ADRs, including:

• Age: Both the very young and the elderly are more susceptible.
• Gender: Some ADRs are more common in one gender.
• Genetic factors: Genetic polymorphisms can affect drug metabolism.
• Polypharmacy: The use of multiple medications increases the risk of drug interactions.
• Comorbidities: Conditions like liver disease or renal impairment can alter drug metabolism and excretion.

Detection and Management

Detection

ADRs can be detected through:

• Patient history and examination
• Laboratory tests
• Monitoring drug levels

Management

Management strategies include:

• Discontinuation of the offending drug
• Dose adjustment
• Symptomatic treatment
• Substitution with an alternative medication

Prevention

Preventing ADRs involves:

• Thorough patient history: Including allergies and previous ADRs.
• Appropriate dosing: Especially in populations at risk.
• Monitoring: Regular monitoring of drug levels and patient response.
• Patient education: Informing patients about potential side effects and what to do if they occur.

Reporting

Healthcare professionals are encouraged to report ADRs to pharmacovigilance programs to improve drug safety and inform regulatory actions.

Also see

• Pharmacovigilance
• Drug interactions
• Side effects
• Toxicology